2023 Form 5500 filing — Inception Therapeutics, Inc. 401(K) Plan

Plain-English filing summary

According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, this is the 2023 Form 5500 filing (EFAST2 acknowledgement 20241011145418NAL0039098048001) for Inception Therapeutics, Inc. 401(K) Plan, reported by Inception Therapeutics, Inc. under EIN 83-2331727 and plan number 001. It reports 59 participants. Attached schedules in the loaded dataset include Schedule I (small plan financials).

Form 5500 2 · 2023

Filing snapshot

Net assets (EOY)$5.9MReported net assets$5,933,997
Participants59
Provider compensationNone reported
Schedules filedSchedule ILoaded schedules
EFAST2 acknowledgement
20241011145418NAL0039098048001
Plan sponsor
Inception Therapeutics, Inc.
EIN
83-2331727
Plan number
001
Location
San Diego, CA
Received date
not reported in the loaded dataset
How to read this filing
  • This is a single annual Form 5500 filing, identified by its EFAST2 acknowledgement id.
  • Schedule chips (Sch H / I / C) show which schedules this filing includes.
  • Net assets = total assets minus total liabilities (Schedule H/I).
  • Fields a filing did not report are labeled not reported in the loaded dataset — never estimated.
  • For the plan's full history, open the plan profile.
Schedule I · 2023

Reported financial snapshot

Reported figures as filed, in whole dollars. Only fields the filing reports are shown.

Reported balance (end of year)$5.9M total assets
Net assets$5.9MLiabilities$0
Money in vs. money out
Total income / additions$1.4M
Total expenses$363.8K
Benefits paid / distributions$339.4K
Contributions
Employer$100.2K
Participant$282.2K
Full reported line items
Total assets (EOY)
$5,933,997
Total liabilities (EOY)
$0
Net assets (EOY)
$5,933,997
Employer contributions
$100,187
Participant contributions
$282,209
Total income / additions
$1,400,119
Benefits paid
$339,429
Administrative expenses
$24,341
Total expenses
$363,770
Net increase / (decrease)
$1,036,349

What to inspect next

Frequently asked questions

What does EFAST2 acknowledgement 20241011145418NAL0039098048001 cover?
It is the 2023 Form 5500 filing for Inception Therapeutics, Inc. 401(K) Plan, reported by Inception Therapeutics, Inc. (EIN 83-2331727).
Which Form 5500 schedules are attached to this 2023 filing?
Attached schedules in the loaded dataset include Schedule I (small plan financials).

Related Form 5500 pages